• Al-Marzooq F, Imad MA, How SH & Kuan YC (2011) Development of multiplex real-time PCR for the rapid detection of five bacterial causes of community acquired pneumonia. Trop Biomed 28: 545556.
  • Baseman JB, Reddy SP & Dallo SF (1996) Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 154: 137144.
  • Beersma MF, Dirven K, Van Dam AP, Templeton KE, Claas EC & Goossens H (2005) Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the ‘gold standard’. J Clin Microbiol 43: 22772285.
  • Chaudhry R, Nisar N, Hora B, Chirasani SR & Malhotra P (2005) Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae. J Clin Microbiol 43: 321325.
  • Drasbek M, Nielsen PK, Persson K, Birkelund S & Christiansen G (2004) Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA. BMC Microbiol 4: 7.
  • Frikha-Gargouri O, Gdoura R, Znazen A, Gargouri B, Gargouri J, Rebai A & Hammami A (2008) Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections. BMC Microbiol 8: 217.
  • Hu PC, Collier AM & Baseman JB (1977) Surface parasitism by Mycoplasma pneumoniae in respiratory epithelium. J Exp Med 145: 13281343.
  • Hu PC, Cole RM, Huang YS, Graham JA, Gardner DE, Collier AM & Clyde WA Jr (1982) Mycoplasma pneumoniae infection: role of a surface protein in the attachment organelle. Science 216: 313315.
  • Kim NH, Lee JA, Eun BW, Shin SH, Chung EH, Park KW, Choi EH & Lee HJ (2007) Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children during two outbreaks. Pediatr Infect Dis J 26: 897903.
  • Kolaskar AS & Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276: 172174.
  • Layh-Schmitt G, Himmelreich R & Leibfried U (1997) The adhesion related 30-kDa protein of Mycoplasma pneumoniae exhibits size and antigen variability. FEMS Microbiol Lett 152: 101108.
  • Morrison-Plummer J, Leith DK & Baseman JB (1986) Biological effects of anti-lipid and anti-protein monoclonal antibodies on Mycoplasma pneumoniae. Infect Immun 53: 398403.
  • Nilsson AC, Björkman P & Persson K (2008) Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 8: 93.
  • Nuyttens H, Cyncynatus C, Renaudin H, Pereyre S & Bébéar C (2010) Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae. BMC Microbiol 10: 216.
  • Pereyre S, Charron A, Renaudin H, Bébéar C & Bébéar CM (2007) First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 45: 35343539.
  • Schurwanz N, Jacobs E & Dumke R (2009) Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development. Infect Immun 77: 50075015.
  • She RC, Thurber A, Hymas WC, Stevenson J, Langer J, Litwin CM & Petti CA (2010) Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections. J Clin Microbiol 48: 33803382.
  • Tabassum I, Chaudhry R, Chourasia BK & Malhotra P (2010) Identification of an N-terminal 27 kDa fragment of Mycoplasma pneumoniae P116 protein as specific immunogen in M. pneumoniae infections. BMC Infect Dis 10: 350.
  • Talkington DF, Shott S, Fallon MT, Schwartz SB & Thacker WL (2004) Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 11: 862867.
  • Thurman KA, Walter ND, Schwartz SB et al. (2009) Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 48: 12441249.
  • Varshney AK, Chaudhry R, Kabra SK & Malhotra P (2008) Cloning, expression, and immunological characterization of the P30 protein of Mycoplasma pneumoniae. Clin Vaccine Immunol 15: 215220.
  • Vervloet LA, Marguet C & Camargos PA (2007) Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz J Infect Dis 11: 507514.
  • Waldo RH & Krause DC (2006) Synthesis, stability, and function of cytadhesin P1 and accessory protein B/C complex of Mycoplasma pneumoniae. J Bacteriol 188: 569575.
  • Waldo RH, Jordan JL & Krause DC (2005) Identification and complementation of a mutation associated with loss of Mycoplasma pneumoniae virulence-specific proteins B and C. J Bacteriol 187: 747751.
  • Walter ND, Grant GB, Bandy U et al. (2008) Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 198: 13651374.
  • Willby MJ & Krause DC (2002) Characterization of a Mycoplasma pneumoniae hmw3 mutant: implications for attachment organelle assembly. J Bacteriol 184: 30613068.
  • Yamazaki T, Narita M, Sasaki N, Kenri T, Arakawa Y & Sasaki T (2006) Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children. Clin Vaccine Immunol 13: 708710.